PCPAX
Price
$22.11
Change
+$0.10 (+0.45%)
Updated
Jun 27 closing price
Net Assets
756.84M
RMEBX
Price
$58.73
Change
+$0.13 (+0.22%)
Updated
Jun 27 closing price
Net Assets
107B
Interact to see
Advertisement

PCPAX vs RMEBX

Header iconPCPAX vs RMEBX Comparison
Open Charts PCPAX vs RMEBXBanner chart's image
PACE Large Co Value Equity A
Price$22.11
Change+$0.10 (+0.45%)
VolumeN/A
Net Assets756.84M
American Funds American Mutual R2E
Price$58.73
Change+$0.13 (+0.22%)
VolumeN/A
Net Assets107B
PCPAX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PCPAX vs. RMEBX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCPAX is a Hold and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 107B vs. PCPAX (757M). PCPAX pays higher dividends than RMEBX: PCPAX (1.42) vs RMEBX (1.16). PCPAX was incepted earlier than RMEBX: PCPAX (25 years) vs RMEBX (11 years). PCPAX (1.14) is less costly to investors than RMEBX (1.07). PCPAX is a more actively managed with annual turnover of: 43.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than PCPAX: RMEBX (250) vs PCPAX (1000). RMEBX annual gain was more profitable for investors over the last year : 9.78 vs. PCPAX (6.94). RMEBX return over 5 years is better than : 63.07 vs. PCPAX (39.63).
PCPAXRMEBXPCPAX / RMEBX
Total Expense Ratio1.141.07107%
Annual Report Gross Expense Ratio1.141.07107%
Fund Existence25 years11 years-
Gain YTD8.4247.553112%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets757M107B1%
Annual Yield % from dividends1.421.16123%
Returns for 1 year6.949.7871%
Returns for 3 years15.9427.2958%
Returns for 5 years39.6363.0763%
Returns for 10 years7.3774.6610%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.940.04
+1.55%
Spero Therapeutics
SHG44.320.16
+0.36%
Shinhan Financial Group Co Ltd
AMED97.94-0.09
-0.09%
Amedisys
VIR5.16-0.14
-2.73%
Vir Biotechnology
DFDV16.82-1.13
-6.27%
DeFi Development Corp